The present invention in one aspect concerns the medical use of zeolite for the prevention and/or treatment of a disorder associated with cholesterol or glycemia and the symptomatology correlated with it. The zeolite can be formulated as a composition for pharmaceutical or dietary use optionally containing glucomannan and a physiologically acceptable carrier.